The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony
Uložené v:
| Názov: | The use of intraluminal PRESERFLO stenting in avoiding early postoperative hypotony |
|---|---|
| Autori: | Raoul Verma-Fuehring, Mohamad Dakroub, Ahmed Bamousa, Gunda Kann, Jost Hillenkamp, Daniel Kampik |
| Zdroj: | Graefes Arch Clin Exp Ophthalmol |
| Informácie o vydavateľovi: | Springer Science and Business Media LLC, 2024. |
| Rok vydania: | 2024 |
| Predmety: | Stents [MeSH], Aged [MeSH], Hypotony, Intraluminal stenting, Ocular Hypotension/physiopathology [MeSH], Intraocular Pressure/physiology [MeSH], Male [MeSH], Postoperative Complications/prevention, Visual Acuity/physiology [MeSH], Preserflo MicroShunt, Suture Techniques/instrumentation [MeSH], Ocular Hypotension/surgery [MeSH], Female [MeSH], Follow-Up Studies [MeSH], Adult [MeSH], Humans [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Glaucoma, Time Factors [MeSH], Glaucoma Drainage Implants [MeSH], Filtering surgery, Tonometry, Ocular [MeSH], Ocular Hypotension/etiology [MeSH], Ocular Hypotension/prevention, Male, Adult, 0301 basic medicine, ddc:610, Time Factors, Suture Techniques, Visual Acuity, Ocular Hypotension, Middle Aged, Tonometry, Ocular, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Humans, Stents, Female, Glaucoma Drainage Implants, Intraocular Pressure, Retrospective Studies, Aged, Follow-Up Studies |
| Popis: | Purpose Postoperative hypotony following PRESERFLO MicroShunt (PMS) implantation is a frequent cause of complications such as choroidal detachment and hypotony maculopathy. This study aims at evaluating the impact of intraluminal stenting of the PMS during the early postoperative period. Methods We retrospectively analyzed the data of 97 patients who underwent PMS implantation with intraoperative placement of a Nylon 10–0 suture as intraluminal stent (PStent) and compared the outcomes to those of an existing database of the traditional MicroShunt implantation technique (PTrad, n = 120). The primary outcome measure was the intraocular pressure (IOP) at one week postoperatively. As a secondary outcome measure, adverse hypotony, defined as an IOP ≤ 5 mmHg with significant choroidal effusion and/or anterior chamber shallowing or the presence of macular folds was also assessed. Additionally, the time to stent removal and the IOP one week after stent removal were reported. Results Preoperative median IOP was 25.0 (20.5–30.3) mmHg in PStent and 25.0 (19.3–32.0) mmHg in PTrad (p = 0.62). One week after surgery, the median IOP dropped to 10.0 (8.0–13.0) mmHg in PStent and 7.0 (5.0–9.0) in PTrad (p p p = 0.66). The presence of adverse hypotony was significantly lower in PStent compared to PTrad (6.2% vs 15.8%, p p Conclusion In the early follow-up period, intraluminal stenting of the PMS appears to be safe and effective in controlling the IOP while reducing early postoperative hypotony. Surgical success is not compromised by stent placement. Based on our data, it is recommended to remove the suture two to six weeks after surgery for most patients with uncomplicated postoperative clinical findings. |
| Druh dokumentu: | Article Other literature type |
| Popis súboru: | application/pdf |
| Jazyk: | English |
| ISSN: | 1435-702X 0721-832X |
| DOI: | 10.1007/s00417-024-06567-x |
| Prístupová URL adresa: | https://pubmed.ncbi.nlm.nih.gov/38969777 https://repository.publisso.de/resource/frl:6505086 https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39268 https://doi.org/10.1007/s00417-024-06567-x https://opus.bibliothek.uni-wuerzburg.de/files/39268/00417_2024_Article_6567.pdf https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-392688 |
| Rights: | CC BY |
| Prístupové číslo: | edsair.doi.dedup.....4c7223bda1be04d81434d8af70619e59 |
| Databáza: | OpenAIRE |
Full Text Finder 
Nájsť tento článok vo Web of Science | Abstrakt: | Purpose Postoperative hypotony following PRESERFLO MicroShunt (PMS) implantation is a frequent cause of complications such as choroidal detachment and hypotony maculopathy. This study aims at evaluating the impact of intraluminal stenting of the PMS during the early postoperative period. Methods We retrospectively analyzed the data of 97 patients who underwent PMS implantation with intraoperative placement of a Nylon 10–0 suture as intraluminal stent (PStent) and compared the outcomes to those of an existing database of the traditional MicroShunt implantation technique (PTrad, n = 120). The primary outcome measure was the intraocular pressure (IOP) at one week postoperatively. As a secondary outcome measure, adverse hypotony, defined as an IOP ≤ 5 mmHg with significant choroidal effusion and/or anterior chamber shallowing or the presence of macular folds was also assessed. Additionally, the time to stent removal and the IOP one week after stent removal were reported. Results Preoperative median IOP was 25.0 (20.5–30.3) mmHg in PStent and 25.0 (19.3–32.0) mmHg in PTrad (p = 0.62). One week after surgery, the median IOP dropped to 10.0 (8.0–13.0) mmHg in PStent and 7.0 (5.0–9.0) in PTrad (p p p = 0.66). The presence of adverse hypotony was significantly lower in PStent compared to PTrad (6.2% vs 15.8%, p p Conclusion In the early follow-up period, intraluminal stenting of the PMS appears to be safe and effective in controlling the IOP while reducing early postoperative hypotony. Surgical success is not compromised by stent placement. Based on our data, it is recommended to remove the suture two to six weeks after surgery for most patients with uncomplicated postoperative clinical findings. |
|---|---|
| ISSN: | 1435702X 0721832X |
| DOI: | 10.1007/s00417-024-06567-x |